C FIN Services (00605) subsidiary granted a loan of 8.5 million yuan.
China Financial Investment Management (00605) announced that on March 16, 2026, Chengkai Microloan (as the lender, a wholly-owned subsidiary controlled by the Company) entered into a loan agreement with customer FS (as the borrower, Ms. Yang Xuebing). According to this agreement, Chengkai Microloan agreed to grant a loan to the borrower in the principal amount of RMB 8.5 million, with a term of 6 months.
C FIN SERVICES (00605) announced that on March 16, 2026, Chengkai Microfinance (as the lender, a wholly-owned subsidiary controlled by the company) entered into a loan agreement with customer FS (as the borrower, Ms. Yang Xuebing). According to this agreement, Chengkai Microfinance agreed to grant a loan of RMB 8.5 million to the borrower for a period of 6 months.
Related Articles
Joinn Laboratories (06127): Shareholder Gu Xiaolei and its concerted action person Gu Meifang intend to reduce their A-share holdings.
CHINA EAST AIR(00670): "21 Donghang 01" will be delisted on March 19th ahead of schedule.
Zhejiang Hisun Pharmaceutical (600267.SH): Haibomai atorvastatin calcium tablets received drug clinical trial approval.
Joinn Laboratories (06127): Shareholder Gu Xiaolei and its concerted action person Gu Meifang intend to reduce their A-share holdings.
CHINA EAST AIR(00670): "21 Donghang 01" will be delisted on March 19th ahead of schedule.
Zhejiang Hisun Pharmaceutical (600267.SH): Haibomai atorvastatin calcium tablets received drug clinical trial approval.
